| Kenneth R Ellis, MD | |
|
1213 24th St, Suite 300, Anacortes, WA 98221-2592 | |
| (360) 293-2020 | |
| (360) 299-0341 |
| Full Name | Kenneth R Ellis |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 26 Years |
| Location | 1213 24th St, Anacortes, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215981022 | NPI | - | NPPES |
| 8351454 | Medicaid | WA | |
| 0163027 | Other | L AND I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00041277 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Island Eye Physicians And Surgeons | 9537056569 | 2 |
News Archive
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In 2006, it was estimated that 18,820 new cases were diagnosed and 12,820 deaths were associated with malignant tumors of the brain and other parts of the central nervous system.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
More and more often, abdominal surgeries are being carried out in a minimally invasive manner. A small incision in the abdominal wall is sufficient for the surgeon to be able to insert the instrument and make the organs visible with an endoscope. This technique is gentler and does not stress the body as much as traditional surgeries do.
› Verified 3 days ago
| Entity Name | Island Eye Physicians & Surgeons |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306893755 PECOS PAC ID: 9537056569 Enrollment ID: O20040303000555 |
News Archive
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In 2006, it was estimated that 18,820 new cases were diagnosed and 12,820 deaths were associated with malignant tumors of the brain and other parts of the central nervous system.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
More and more often, abdominal surgeries are being carried out in a minimally invasive manner. A small incision in the abdominal wall is sufficient for the surgeon to be able to insert the instrument and make the organs visible with an endoscope. This technique is gentler and does not stress the body as much as traditional surgeries do.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth R Ellis, MD 1213 24th St, Suite 300, Anacortes, WA 98221-2592 Ph: (360) 293-2020 | Kenneth R Ellis, MD 1213 24th St, Suite 300, Anacortes, WA 98221-2592 Ph: (360) 293-2020 |
News Archive
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In 2006, it was estimated that 18,820 new cases were diagnosed and 12,820 deaths were associated with malignant tumors of the brain and other parts of the central nervous system.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
More and more often, abdominal surgeries are being carried out in a minimally invasive manner. A small incision in the abdominal wall is sufficient for the surgeon to be able to insert the instrument and make the organs visible with an endoscope. This technique is gentler and does not stress the body as much as traditional surgeries do.
› Verified 3 days ago
Linda R Brown, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1213 24th St, Suite 300, Anacortes, WA 98221 Phone: 360-293-2020 Fax: 360-299-0341 |